Comparison of the relative bioavailability and pharmacokinetics of carbamazepine tablets and chewable tablet formulations
Maas, B.; Garnett, W.R.; Comstock, T.J.; Pellock, J.M.
Annals of Neurology 18(3): 379
1985
ISSN/ISBN: 0364-5134 Accession: 027979497
PDF emailed within 1 workday: $29.90
Related References
Lücker, P.W.; Wetzelsberger, N.; Schettler, T.; Rogalla, K. 1992: Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet Methods and Findings in Experimental and Clinical Pharmacology 14(10): 805-811Maas, B.; Garnett, W.R.; Pellock, J.M.; Comstock, T.J. 1987: A comparative bioavailability study of carbamazepine tablets and a chewable tablet formulation Therapeutic Drug Monitoring 9(1): 28-33
Abbas, R.; Palumbo, D.; Walters, F.; Belden, H.; Berry, S.A. 2016: Single-dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-release Chewable Tablet Compared with Immediate-release Methylphenidate Chewable Tablet Clinical Therapeutics 38(5): 1151-1157
Degen, J.; Bruno, L.; Seiberling, M.; Schepers, C.; Brickl, R. 1992: Pharmacocinétique et biodisponibilité relative de deux formulations de dipyridamole (75 et 150 mg) après administration d'une prise unique orale à des volontaires sains - Pharmacokinetics and relative bioavailability of two tablet formulations (75 and 150 mg) of dipyridamole given as single dose to healthy male volunteers Comptes Rendus de Therapeutique et de Pharmacologie Clinique (108): 16-21
Nath, R.P.; Upton, R.A.; Everhart, E.T.; Cheung, P.; Shwonek, P.; Jones, R.T.; Mendelson, J.E. 1999: Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations Journal of Clinical Pharmacology 39(6): 619-623
Helmy, S.A. 2013: Pharmacokinetics and relative bioavailability evaluation of linezolid suspension and tablet formulations Drug Research 63(9): 489-494
Helmy, S.A. 2013: Pharmacokinetics and Relative Bioavailability Evaluation of Linezolid Suspension and Tablet Formulations Drug Research (Stuttgart 2013. Print) 63(9): 489-494
Cai, H.; Luo, Q.; Dai, J.; Wang X R. 1990: Relative bioavailability of zinc gluconate tablets and chewable tablets in human Zhongguo Yiyao Gongye Zazhi 21(10): 452-454
Elshattawy, H.; Fetouh, M.I.; Khattab, I. 1995: Comparative bioavailability of acetaminophen from three super disintegrants-containing tablet formulations using topspray fluid-bed granulation relative to conventional tablets in humans Pharmaceutical Research (New York) 12(9 Suppl): S416
Coll, J.; Ayres, J.W. 1996: Pharmacokinetics and bioavailability of a novel amoxicillin/clavulanate chewable tablet formulation Pharmaceutical Research (New York) 13(9 Suppl): S458
Kim, H.T.; Song, Y.-K.; Lee, S.D.; Park, Y.; Kim, C.-K. 2012: Relative bioavailability of two 5-mg montelukast sodium chewable tablets: a single dose, randomized, open-label, 2-period crossover comparison in healthy korean adult male volunteers Arzneimittel-Forschung 62(3): 123-127
Wardrop, J.; Jaber, A.B.; Ayres, J.W. 1998: Multiple-layer compression-coated tablets: formulation and humidity studies of novel chewable amoxicillin/clavulanate tablet formulations Drug Development and Industrial Pharmacy 24(8): 729-736
Birnbaum, A.K.; Kriel, R.L.; Im, Y.; Remmel, R.P. 2001: Relative bioavailability of lamotrigine chewable dispersible tablets administered rectally Pharmacotherapy 21(2): 158-162
Ullah, M.; Murtaza, G.; Hussain, I. 2016: Relative Bioavailability Study of Succinic Acid Cocrystal Tablet and Marketed Conventional Immediate Release Tablet Formulation of Carbamazepine 200 Mg in Rabbits Acta Poloniae Pharmaceutica 73(5): 1412
Camarillo Cárdenas, K.P.; García González, J.; Argüelles Tello, F.A.; Ocampo Ramírez, J.A.; Moreno Hernández, J.é B.; Pendela, M.M. 2022: Relative bioavailability and pharmacokinetic comparison of a fixed-dose combination tablet of mosapride, pancreatin, and simethicone relative to single-component mosapride tablets in healthy Mexican subjects Fundamental and Clinical Pharmacology 36(2): 427-435
Abbas, R.; Childress, A.C.; Nagraj, P.; Rolke, R.; Berry, S.A.; Palumbo, D.R. 2018: Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole Clinical Therapeutics 40(5): 733-740
E.S.attawy, H.; Kassem, A.; Zaghloul, A. 1997: Comparative kinetics and bioavailability of bioadhesives containing or not-containing ketoprofen tablet formulations relative to conventional tablet in humans Pharmaceutical Research (New York) 14(11 Suppl): S249
Oluka, M.O.; Mitema, E.S.; Kibwage, I.O.; Kwasa, T.O.; Kokwaro, G.O. 1996: A comparative bioavailability of four Carbamazepine tablet formulations available in the Kenyan market East African Medical Journal 73(5): 323-326
Paul, A.J.; Todd, K.S.; Acre, K.E.; Plue, R.E.; Wallace, D.H.; French, R.A.; Wallig, M.A. 1991: Efficacy of ivermectin chewable tablets and two new ivermectin tablet formulations against Dirofilaria immitis larvae in dogs American Journal of Veterinary Research 52(11): 1922-1923
Shevchenko, R.V.; Litvin, A.A.; Kolyvanov, G.B.; Zherdev, V.P.; Smirnov, V.V. 2014: Comparison of pharmacokinetics and relative bioavailability of tablets and substance of new dipeptide neuroleptic dilept Bulletin of Experimental Biology and Medicine 157(6): 735-737